4B24

ICD-11 MMS 2026-01

Graft-versus-host disease

Description

Graft-versus-host disease (GVHD) occurs when lymphoid cells from an immunocompetent donor are introduced into a histo-incompatible recipient incapable of rejecting them. This usually occurs as a result of haematopoietic stem cell transplantation. The main targets attacked by the donor lymphocytes are the recipient’s skin, gastrointestinal tract and liver. Acute GVHD, normally occurring within the first 100 days following transplantation, has a high mortality. The acute phase may be followed by chronic GVHD, which can also arise de novo. This usually presents as a lichenoid rash but can develop into a severe fibrosing disease affecting skin, lungs and liver.

Exclusions from above levels

  • 2A83.0 – Monoclonal gammopathy of undetermined significance
  • NE84 – Failure or rejection of transplanted organs or tissues
  • 02 – Neoplasms
Show allHide
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 20 – Developmental anomalies

Child codes

  • 4B24.0 – Acute graft-versus-host disease
  • 4B24.1 – Chronic graft-versus-host disease
  • 4B24.Y – Other specified graft-versus-host disease
  • 4B24.Z – Graft-versus-host disease, unspecified

Sibling codes

  • 4B20 – Sarcoidosis
  • 4B21 – Polyclonal hypergammaglobulinaemia
  • 4B22 – Cryoglobulinaemia
  • 4B23 – Immune reconstitution inflammatory syndrome
  • 4B2Y – Other specified disorders involving the immune system

Foundation entity

Graft-versus-host disease – http://id.who.int/icd/entity/437372167

Allowed postcoordination axes

Part of: 04: Diseases of the immune system